A mapping review of Pacific Vascular Symposium 6 initiatives

Oscar Moreno; Kiran Kumar; Fedor Lurie; Marc A Passman; Glen Jacobowitz; Faisal Aziz; Peter Henke; Thomas Wakefield; Andrea Obi

doi:10.1016/j.jvsv.2023.101723

A mapping review of Pacific Vascular Symposium 6 initiatives

J Vasc Surg Venous Lymphat Disord. 2023 Dec 20:101723. doi: 10.1016/j.jvsv.2023.101723. Online ahead of print.

Authors

Oscar Moreno¹, Kiran Kumar¹, Fedor Lurie², Marc A Passman³, Glen Jacobowitz⁴, Faisal Aziz⁵, Peter Henke¹, Thomas Wakefield¹, Andrea Obi⁶

Affiliations

¹ Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
² Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI; Jobst Vascular Institute of ProMedica, Toledo, OH.
³ UAB Vein Program and Clinic, Department of Surgery, The University of Alabama at Birmingham, Birmingham, AL.
⁴ Section of Vascular Surgery, Department of Surgery, New York University, New York, NY.
⁵ Division of Vascular Surgery, Department of Surgery, The Pennsylvania State University, Hershey, PA.
⁶ Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI. Electronic address: easta@med.umich.edu.

PMID: 38135216
DOI: 10.1016/j.jvsv.2023.101723

Abstract

Objective: The 2010 Pacific Vascular Symposium 6 (PVS6) brought venous disease content experts together with a goal of addressing critical issues collated together in the next decade with concrete plans to achieve these goals. This mapping review aims to provide a broader representation of how progress in critical issues of chronic venous disease has been made by extrapolating scientific publications related to the PVS6 initiatives.

Methods: We performed a mapping review identifying original or systematic review/meta-analysis articles related to PVS 6 initiatives (aims) that addressed one of the following key objectives: scales to measure chronic venous disease, effectiveness of interventional deep venous thrombus removal, development of a deep venous valve, and biomarkers related to venous disease. Searches were undertaken in PubMed, Ovid Medline, Cochrane Library, Embase (Elsevier), CINAHL (EBSCO), and Scopus. We extracted descriptive information about the studies and predefined variables for each specific aim, showing what and where research exists on the aims included.

Results: A total of 2138 articles were screened from 3379 retrieved articles from six electronic databases. We mapped 186 included articles, finding that the total number of publications significantly increased after the 2010 PVS6 meeting. Aim results were visually summarized. The largest body of data addressed catheter-based thrombus removal strategies for acute iliofemoral deep venous thrombosis. Primary research on artificial venous valves and venous biomarkers remained limited. No new post-thrombotic syndrome (PTS) score has been developed.

Conclusions: This mapping review identified and characterized the available evidence and gaps in our knowledge of chronic venous disease that exist visually, which may guide where more significant investments for the future should be targeted.

Keywords: Chronic venous disease; Mapping review; Pacific Vascular Symposium.

Publication types

Review